ARTICLE | Clinical News
Ceprate SC Stem Cell Concentration System: Pilot study of Ceprate in patients with malignant multiple sclerosis.
June 3, 1996 7:00 AM UTC
CellPro Inc. (CPRO), Seattle, Wash. Product: Ceprate SC Stem Cell Concentration System Indication: Multiple sclerosis Status: CPRO began a pilot study of Ceprate in 20 patients with malignant multiple...